These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 34825155)
21. Automated CT LI-RADS v2018 scoring of liver observations using machine learning: A multivendor, multicentre retrospective study. Mulé S; Ronot M; Ghosn M; Sartoris R; Corrias G; Reizine E; Morard V; Quelever R; Dumont L; Hernandez Londono J; Coustaud N; Vilgrain V; Luciani A JHEP Rep; 2023 Oct; 5(10):100857. PubMed ID: 37771548 [TBL] [Abstract][Full Text] [Related]
22. Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review. van der Pol CB; Lim CS; Sirlin CB; McGrath TA; Salameh JP; Bashir MR; Tang A; Singal AG; Costa AF; Fowler K; McInnes MDF Gastroenterology; 2019 Mar; 156(4):976-986. PubMed ID: 30445016 [TBL] [Abstract][Full Text] [Related]
23. CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis. van der Pol CB; McInnes MDF; Salameh JP; Levis B; Chernyak V; Sirlin CB; Bashir MR; Allen BC; Burke LMB; Choi JY; Choi SH; Forner A; Fraum TJ; Giamperoli A; Jiang H; Joo I; Kang Z; Kierans AS; Kang HJ; Khatri G; Kim JH; Kim MJ; Kim SY; Kim YY; Kwon H; Lee JM; Lewis SC; McGinty KA; Mulazzani L; Park MS; Piscaglia F; Podgórska J; Reiner CS; Ronot M; Rosiak G; Song B; Song JS; Tang A; Terzi E; Wang J; Wang W; Wilson SR; Yokoo T Radiology; 2022 Feb; 302(2):326-335. PubMed ID: 34783596 [TBL] [Abstract][Full Text] [Related]
24. Imaging and prognostic characterization of fat-containing hepatocellular carcinoma subtypes. Faure A; Dioguardi Burgio M; Cannella R; Sartoris R; Bouattour M; Hobeika C; Cauchy F; Trapani L; Beaufrère A; Vilgrain V; Ronot M Radiol Med; 2024 May; 129(5):687-701. PubMed ID: 38512627 [TBL] [Abstract][Full Text] [Related]
25. LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation. Min JH; Lee MW; Rhim H; Han S; Song KD; Kang TW; Jeong WK; Cha DI; Kim JM; Choi GS; Kim K Eur Radiol; 2024 Jan; 34(1):525-537. PubMed ID: 37526668 [TBL] [Abstract][Full Text] [Related]
26. Hepatic Steatosis Has No Effect in Diagnosis Accuracy of LI-RADS v2018 Categorization of Hepatocellular Carcinoma in MR Imaging. Yao S; Wei Y; Ye Z; Chen J; Duan T; Zhang Z; Song B J Magn Reson Imaging; 2024 Jun; 59(6):2060-2070. PubMed ID: 34121266 [TBL] [Abstract][Full Text] [Related]
27. Comparison of imaging findings of macrotrabecular-massive hepatocellular carcinoma using CT and gadoxetic acid-enhanced MRI. Cha H; Choi JY; Park YN; Han K; Jang M; Kim MJ; Park MS; Rhee H Eur Radiol; 2023 Feb; 33(2):1364-1377. PubMed ID: 35999373 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of different LI-RADS v2018 categories in high-risk patients undergoing CT- or MRI-based screening for hepatocellular carcinoma. Shahbazian H; Birnbaum J; Burns PJ; Shabanan SH; Kanmaniraja D; Reinus J; Kamel I; Sirlin CB; Chernyak V Abdom Radiol (NY); 2023 Dec; 48(12):3696-3702. PubMed ID: 37725110 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic Performance of LI-RADS Version 2018 for Evaluation of Pediatric Hepatocellular Carcinoma. Khanna G; Chavhan GB; Schooler GR; Fraum TJ; Alazraki AL; Squires JH; Salter A; Podberesky DJ; Towbin AJ Radiology; 2021 Apr; 299(1):190-199. PubMed ID: 33620289 [TBL] [Abstract][Full Text] [Related]
30. Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging. Jeon SK; Joo I; Lee DH; Lee SM; Kang HJ; Lee KB; Lee JM Eur Radiol; 2019 Jan; 29(1):373-382. PubMed ID: 29955948 [TBL] [Abstract][Full Text] [Related]
31. Liver Imaging Reporting and Data System: Discordance Between Computed Tomography and Gadoxetate-Enhanced Magnetic Resonance Imaging for Detection of Hepatocellular Carcinoma Major Features. Chernyak V; Flusberg M; Law A; Kobi M; Paroder V; Rozenblit AM J Comput Assist Tomogr; 2018; 42(1):155-161. PubMed ID: 28806321 [TBL] [Abstract][Full Text] [Related]
32. Risk Stratification and Distribution of Hepatocellular Carcinomas in CEUS and CT/MRI LI-RADS: A Meta-Analysis. Zhou Y; Qin Z; Ding J; Zhao L; Chen Y; Wang F; Jing X Front Oncol; 2022; 12():873913. PubMed ID: 35425706 [TBL] [Abstract][Full Text] [Related]
33. LI-RADS v2014 categorization of hepatocellular carcinoma: Intraindividual comparison between gadopentetate dimeglumine-enhanced MRI and gadoxetic acid-enhanced MRI. Song JS; Choi EJ; Hwang SB; Hwang HP; Choi H Eur Radiol; 2019 Jan; 29(1):401-410. PubMed ID: 29922928 [TBL] [Abstract][Full Text] [Related]
34. Multi-arterial phase MRI depicts inconsistent arterial phase hyperenhancement (APHE) subtypes in liver observations of patients at risk for hepatocellular carcinoma. Cunha GM; Hasenstab KA; Delgado T; Ichikawa S; Lee MH; Dautt Medina PM; Kim SJ; Lee YH; Kwon H; Sirlin CB; Fowler KJ Eur Radiol; 2021 Oct; 31(10):7594-7604. PubMed ID: 33876298 [TBL] [Abstract][Full Text] [Related]
35. MRI features associated with HCC histologic subtypes: a western American and European bicenter study. Mulé S; Serhal A; Pregliasco AG; Nguyen J; Vendrami CL; Reizine E; Yang GY; Calderaro J; Amaddeo G; Luciani A; Miller FH Eur Radiol; 2023 Feb; 33(2):1342-1352. PubMed ID: 35999375 [TBL] [Abstract][Full Text] [Related]
36. Should Threshold Growth Be Considered a Major Feature in the Diagnosis of Hepatocellular Carcinoma Using LI-RADS? Park JH; Chung YE; Seo N; Choi JY; Park MS; Kim MJ Korean J Radiol; 2021 Oct; 22(10):1628-1639. PubMed ID: 34269533 [TBL] [Abstract][Full Text] [Related]
37. Liver imaging reporting and data system v2014 categorization of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Comparison with multiphasic multidetector computed tomography. Joo I; Lee JM; Lee DH; Ahn SJ; Lee ES; Han JK J Magn Reson Imaging; 2017 Mar; 45(3):731-740. PubMed ID: 27474328 [TBL] [Abstract][Full Text] [Related]
38. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma? Huang JY; Li JW; Ling WW; Li T; Luo Y; Liu JB; Lu Q World J Gastroenterol; 2020 Jul; 26(27):3938-3951. PubMed ID: 32774068 [TBL] [Abstract][Full Text] [Related]
39. Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS. Ding J; Long L; Zhang X; Chen C; Zhou H; Zhou Y; Wang Y; Jing X; Ye Z; Wang F Eur Radiol; 2021 Feb; 31(2):847-854. PubMed ID: 32803416 [TBL] [Abstract][Full Text] [Related]
40. LI-RADS version 2018 for hepatocellular carcinoma < 1.0 cm on gadoxetate disodium-enhanced magnetic resonance imaging. Jang HJ; Choi SH; Choi SJ; Choi WM; Byun JH; Won HJ; Shin YM Eur Radiol; 2023 Aug; 33(8):5792-5800. PubMed ID: 37017700 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]